Deals
Organon's Third-Quarter Adjusted Earnings Slip To $0.94 A Share, And There Is No Earnings Call
Adjusted EBITDA fell to $502 million from $518 million as the pending Sun Pharmaceutical merger replaced the usual release and call.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Deals
Adjusted EBITDA fell to $502 million from $518 million as the pending Sun Pharmaceutical merger replaced the usual release and call.
SEC Filings
The retention pay sits outside the purchase price and will be expensed over what the company generally puts at one to three years.
Earnings
Four established brands now carry the "Supply Constraints" label as full recovery of the supply chains is still ongoing, the company says.
Earnings
Downstream earnings hit C$1,555 million and Imperial returned C$2,506 million to holders, even as Kearl output slid.
SEC Filings
LCI's board says the offer is below its bankers' range and backs the all-stock Patrick deal ahead of November 18 votes.
Earnings
Third-quarter LUPKYNIS sales rose 12%, and nine-month cash from operations reached $131.5 million.
SEC Filings
The new chief administrative officer role takes effect January 4, 2027, and Daniels will keep no mention of pumps duties in the filing.
SEC Filings
The Calgary oil company says it has paid dividends every year for over a century, with the next payment due January 1, 2027.
Deals
The offer has no financing condition and follows an October 8 merger agreement, with Pacira shares closing Thursday at $36.39.
Earnings
Operating earnings reached $1.28 per share in the third quarter, up from $1.06, and the utility reaffirmed its dividend and credit guidance.
SEC Filings
The state's September order called the Ozaukee application "unreasonably complicated"; ATC refiled, and WEC's capital plan now stands at $47.5 billion.
SEC Filings
The drugmaker also lifted its quarterly dividend 5.2% to $1.82 and completed its Apogee Therapeutics purchase as Humira sales fell.